LPL Financial’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-22,130
Closed -$1.88M 3920
2020
Q3
$1.88M Buy
+22,130
New +$1.12M ﹤0.01% 1502
2019
Q2
Sell
-15,945
Closed -$306K 3378
2019
Q1
$306K Sell
15,945
-43
-0.3% -$693 ﹤0.01% 2618
2018
Q4
$228K Buy
15,988
+3,309
+26% +$65.7K ﹤0.01% 2710
2018
Q3
$264K Buy
12,679
+228
+2% +$5.4K ﹤0.01% 2794
2018
Q2
$295K Sell
12,451
-923
-7% -$18.6K ﹤0.01% 2665
2018
Q1
$195K Sell
13,374
-476
-3% -$7.78K ﹤0.01% 2962
2017
Q4
$224K Buy
13,850
+777
+6% +$9.17K ﹤0.01% 2733
2017
Q3
$183K Buy
13,073
+2,023
+18% +$20.2K ﹤0.01% 2684
2017
Q2
$98K Buy
11,050
+1,000
+10% +$7.02K ﹤0.01% 2716
2017
Q1
$63K Buy
+10,050
New +$50.9K ﹤0.01% 2645

LPL Financial's IMMU Position: Q4 2020 in Review

LPL Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 22,130 shares — an estimated $1.88M sold.

LPL Financial first reported a position in IMMU in Q1 2017 and held it in 10 quarters. The position peaked at $1.88M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • LPL Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • LPL Financial sold 22,130 Immunomedics Inc shares in Q4 2020, an estimated $1.88M.
  • LPL Financial first reported a position in Immunomedics Inc in Q1 2017 and held it in 10 quarters.
  • LPL Financial's Immunomedics Inc position peaked at $1.88M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on LPL Financial's 13F filing for Q4 2020, filed 12 Feb 2021.